share_log

宣泰医药(688247.SH)：上半年净利润5415.33万元 同比增长137.6%

Xuantai Pharmaceuticals (688247.SH): Net income in the first half of the year was 54.1533 million yuan, a year-on-year increase of 137.6%.

Gelonghui Finance ·  Aug 30 05:54

On August 30th, Gelonghui announced its semi-annual report. During the reporting period, the company achieved a revenue of 217.9946 million yuan, a year-on-year increase of 96.81%; the net profit attributable to the owners of the parent company was 54.1533 million yuan, a year-on-year increase of 137.60%; the net profit attributable to the owners of the parent company after deducting non-recurring gains and losses was 48.7934 million yuan, a year-on-year increase of 167.97%. The company plans to distribute a cash dividend of 0.25 yuan per 10 shares to all shareholders.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment